Cargando…
In Silico Analysis of Six Known Leishmania major Antigens and In Vitro Evaluation of Specific Epitopes Eliciting HLA-A2 Restricted CD8 T Cell Response
BACKGROUND: As a potent CD8(+) T cell activator, peptide vaccine has found its way in vaccine development against intracellular infections and cancer, but not against leishmaniasis. The first step toward a peptide vaccine is epitope mapping of different proteins according to the most frequent HLA ty...
Autores principales: | Seyed, Negar, Zahedifard, Farnaz, Safaiyan, Shima, Gholami, Elham, Doustdari, Fatemeh, Azadmanesh, Kayhan, Mirzaei, Maryam, Saeedi Eslami, Nasir, Khadem Sadegh, Akbar, Eslami far, Ali, Sharifi, Iraj, Rafati, Sima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167772/ https://www.ncbi.nlm.nih.gov/pubmed/21909442 http://dx.doi.org/10.1371/journal.pntd.0001295 |
Ejemplares similares
-
Human Neutrophil Peptide-1 (HNP-1): A New Anti-Leishmanial Drug Candidate
por: Dabirian, Sara, et al.
Publicado: (2013) -
Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
por: Zahedifard, Farnaz, et al.
Publicado: (2014) -
Antibiotic-Free Nanoplasmids as Promising Alternatives for Conventional DNA Vectors
por: Seyed, Negar, et al.
Publicado: (2022) -
Novel strategy using live non-pathogenic Leishmania expressing selected parasite antigens as a candidate vaccine for leishmaniasis
por: Rafati, Sima, et al.
Publicado: (2011) -
Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice
por: Abdossamadi, Zahra, et al.
Publicado: (2017)